ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
48 hedge funds and large institutions have $4.66M invested in Oncternal Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
96% less capital invested
Capital invested by funds: $104M → $4.66M (-$99.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
48
Holding in Top 10
–
Calls
$540K
Puts
$1.32M
Top Buyers
| 1 | +$431K | |
| 2 | +$410K | |
| 3 | +$322K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$299K |
| 5 |
Millennium Management
New York
|
+$291K |
Top Sellers
| 1 | -$23M | |
| 2 | -$20.1M | |
| 3 | -$13M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$5.91M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$5.42M |